Musk's plan to build a "Terafab" that matches TSMC's 2nm scale by 2030 is laughable, but it provides a further pump for his SpaceX IPO & an excuse for Tesla to finance.
Join the Intelligence Network
Institutional Research Straight to Your Inbox
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.